Cargando…

Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization

INTRODUCTION: Dalbavancin is a bactericidal lipoglycopeptide active against gram-positives. Its use has been approved for the treatment of acute bacterial skin and skin structure infections (ABSSSI). METHODS: We conducted a narrative review of the literature on the safety profile of dalbavancin. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simonetti, Oriana, Rizzetto, Giulio, Molinelli, Elisa, Cirioni, Oscar, Offidani, Annamaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997409/ https://www.ncbi.nlm.nih.gov/pubmed/33790563 http://dx.doi.org/10.2147/TCRM.S271445

Ejemplares similares

The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa
por: Molinelli, Elisa, et al.
Publicado: (2022)

New Perspectives on Old and New Therapies of Staphylococcal Skin Infections: The Role of Biofilm Targeting in Wound Healing
por: Simonetti, Oriana, et al.
Publicado: (2021)

Safety and Efficacy of Vaccines during COVID-19 Pandemic in Patients Treated with Biological Drugs in a Dermatological Setting
por: Simonetti, Oriana, et al.
Publicado: (2021)

MRSA and Skin Infections in Psoriatic Patients: Therapeutic Options and New Perspectives
por: Rizzetto, Giulio, et al.
Publicado: (2022)

Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management
por: Simonetti, Oriana, et al.
Publicado: (2022)

Role of Daptomycin in Cutaneous Wound Healing: A Narrative Review
por: Rizzetto, Giulio, et al.
Publicado: (2022)

Efficacy of Pembrolizumab in Advanced Melanoma: A Narrative Review
por: Rizzetto, Giulio, et al.
Publicado: (2023)

Our Experience over 20 Years: Antimicrobial Peptides against Gram Positives, Gram Negatives, and Fungi
por: Rizzetto, Giulio, et al.
Publicado: (2022)

Baricitinib: The First Jak Inhibitor Approved in Europe for the Treatment of Moderate to Severe Atopic Dermatitis in Adult Patients
por: Radi, Giulia, et al.
Publicado: (2021)

Biological Treatments for Pediatric Psoriasis: State of the Art and Future Perspectives
por: Diotallevi, Federico, et al.
Publicado: (2022)

The Role of Diet in Children with Psoriasis: Emerging Evidence and Current Issues
por: De Simoni, Edoardo, et al.
Publicado: (2023)

Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review
por: Marani, Andrea, et al.
Publicado: (2022)

Systemic Antibiotic Therapy in Hidradenitis Suppurativa: A Review on Treatment Landscape and Current Issues
por: Molinelli, Elisa, et al.
Publicado: (2023)

Tissue Biomarkers Predicting Lymph Node Status in Cutaneous Melanoma
por: Rizzetto, Giulio, et al.
Publicado: (2022)

New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa
por: Molinelli, Elisa, et al.
Publicado: (2023)

Oxidative Stress and Alterations of Paraoxonases in Atopic Dermatitis
por: Simonetti, Oriana, et al.
Publicado: (2021)

Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild‐to‐moderate hidradenitis suppurativa: A retrospective study
por: Molinelli, Elisa, et al.
Publicado: (2022)

Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model
por: Simonetti, Oriana, et al.
Publicado: (2021)

Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate‐to‐severe hidradenitis suppurativa
por: Molinelli, Elisa, et al.
Publicado: (2022)

Metabolic Comorbidities in Pediatric Atopic Dermatitis: A Narrative Review
por: De Simoni, Edoardo, et al.
Publicado: (2022)

Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma
por: Lucarini, Guendalina, et al.
Publicado: (2022)

Characterization and Clonal Diffusion of Ceftaroline Non-Susceptible MRSA in Two Hospitals in Central Italy
por: Morroni, Gianluca, et al.
Publicado: (2021)

Evaluating the Use of Dalbavancin for Off-Label Indications
por: Taylor, Katherine, et al.
Publicado: (2022)

Primary Dermal Melanoma: A Rare Clinicopathological Variant Mimicking Metastatic Melanoma
por: Simonetti, Oriana, et al.
Publicado: (2021)

614. Evaluating the Use of Dalbavancin for Off-Label Indications
por: Taylor, Katherine, et al.
Publicado: (2021)

CT Patterns of Interstitial Lung Disease in Patients with Plaque Psoriasis: A Retrospective Case Series Study
por: Rizzetto, Giulio, et al.
Publicado: (2023)

The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches
por: Emanuelli, Monica, et al.
Publicado: (2022)

Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art
por: Diotallevi, Federico, et al.
Publicado: (2023)

Reticulated acanthoma with sebaceous differentiation
por: Molinelli, Elisa, et al.
Publicado: (2021)

Efficacy of the Quorum Sensing Inhibitor FS10 Alone and in Combination with Tigecycline in an Animal Model of Staphylococcal Infected Wound
por: Simonetti, Oriana, et al.
Publicado: (2016)

Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study
por: Molinelli, Elisa, et al.
Publicado: (2020)

The Efficacy of the Quorum Sensing Inhibitor FS8 and Tigecycline in Preventing Prosthesis Biofilm in an Animal Model of Staphylococcal Infection
por: Simonetti, Oriana, et al.
Publicado: (2013)

Dalbavancin
por: Barberán, José, et al.
Publicado: (2021)

Sneddon-Wilkinson Disease and Monoclonal Gammopathy of Undetermined Significance in the Elderly: Case Report
por: Ceccarelli, Gabriele, et al.
Publicado: (2019)

314. A Retrospective Review of Dalbavancin Utilization at an Academic Medical Center
por: Napoli, Emma, et al.
Publicado: (2020)

Should we be concerned about gastrointestinal‐related adverse events in patients with plaque psoriasis receiving secukinumab therapy? A retrospective, real‐life study
por: Diotallevi, Federico, et al.
Publicado: (2022)

Fluorescence‐guided surgery for non‐melanoma and melanoma skin cancer: Case series and a brief review of the literature
por: Ivan, Bobyr, et al.
Publicado: (2021)

Off-Label Use of Dalbavancin for Sequential Treatment of Spondylodiscitis by Methicillin-Resistant Staphylococcus aureus: A Retrospective Single-Centre Experience
por: Mazzitelli, Maria, et al.
Publicado: (2022)

Use of Dalbavancin in Skin, Bone and Joint Infections: A Real-Life Experience in an Italian Center
por: Brescini, Lucia, et al.
Publicado: (2021)

Dalbavancin in Bone and Joint Infections: A Systematic Review
por: Lovatti, Sofia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6l6cnbnqbdecih21off87fr8f7